Silencing caveolin-1 results in inhibition of osteoclast formation and protection against ovariectomy (OVX)-induced osteoporosis (Lee et al., 2015a; Lee et al., 2015b; Zou et al., 2021). The gene discussed is CAV1; the disease is osteoporosis.